Course Date

February 22, 2025.

Course Description

This ISCD Orthopedic Osteoporosis and Densitometry Course is a live activity consisting of a variety of sessions in didactic lectures, question and answer sessions and case-based interactive presentations. Overall, this variety of learning formats will allow learners to receive information from leading experts in important topic areas. Further, the structure and format of the course will provide learners with opportunities to engage with and learn from their colleagues. The case presentations are designed to provide learners with tangible examples that they might face in their own professional practice.  Further, panel discussions provide a forum for discussing key components of orthopedic densitometry.

This activity was developed with the support of an educational donation provided by Amgen.

Target Audience

The ISCD Orthopedic Osteoporosis and Densitometry Course is designed for healthcare professionals with an interest in orthopedics, osteoporosis, and bone health specifically over the age of 50, including those working in orthopedics, radiology and diagnostic imaging, physical and occupational therapy, public health, and research. These include orthopedic surgeons, physicians, nurses, nurse practitioners, physician assistants, radiology technologists, physical therapists, and occupational therapists. 

Osteoporosis, both primary and secondary, is a common problem leading to fragility fractures and poor outcomes of elective orthopedic surgery. Although orthopedic surgeons care for the majority of patients having fractures, there is a need to support training in current methods of bone health assessment, including bone densitometry. The under-diagnosis and treatment of osteoporosis continues to occur even though effective therapy exists to improve bone health and to reduce fracture risk. This gap in osteoporosis diagnosis and treatment contributes to the epidemic of new fractures and complications related to poor bone health in elective orthopedic surgery. Those caring for orthopedic patients must be familiar with and aware of current guidelines regarding osteoporosis diagnosis, fracture risk assessment, and a basic understanding of therapeutic agents.

In addition to fracture prevention and post fracture care, elective orthopedic surgery patients over age of 50 years have a significant risk of having poor bone health including osteoporosis.  Poor bone health has been associated with many adverse events of elective orthopedic surgery including periprosthetic fracture, implant subsidence, non-union and delayed union, hardware loosening, revision surgery, and overall poorer patient reported outcomes. In spine surgery, similar adverse events can occur including proximal junction failure at the end of fusions, proximal fracture with neurologic injury, and revision surgery. Unfortunately, less than 5% of orthopedic surgeons order testing for bone health prior to elective surgery.

To close the diagnosis gap, this course will review osteoporosis diagnosis guidelines, diagnostic testing basics including the application and interpretation of bone densitometry, and newer methods to assess bone health of fracture and elective surgery patients. Further, the course addresses how to initiate treatment based on clinical assessment and published guidelines. The dissemination of evidence-based information on risk/benefit balance could help reduce the treatment gap and improve patient health. Orthopedic surgeons and other members of the healthcare team may be unfamiliar with how elevated fracture risk and prevalent fragility fracture warrants pharmacological intervention of osteoporosis.

Lastly, osteoporosis is widely recognized as an important public health problem because of the related morbidity, mortality and high cost associated with fracture. Bone mineral density (BMD) measurement by dual-energy x-ray absorptiometry (DXA) is an internationally accepted standard-of-care screening and osteoporosis diagnostic tool. This course provides essential information regarding BMD acquisition, interpretation and monitoring.

Learning Objectives

After attending the course, participants should be better prepared to:

1. Describe the principles of DXA including indications, interpretation, monitoring and potential pitfalls.
2. Utilize advanced densitometry techniques such as trabecular bone score, vertebral fracture assessment, and opportunistic CT in clinical practice.
3. Ensure all fragility fracture patients receive secondary fracture care.
4. Screen elective surgery patients over age 50 years for poor bone health and provide access to osteoporosis care if warranted.
5. Understand various pharmacological treatments available and treatment algorithms.
6. Understanding the importance of sarcopenia, frailty, fall risk assessment and fall prevention.

Method of Participation

This activity will be offered in person in Boston, allowing the learner to watch and ask questions in a live format on February 22, 2025. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

Rates

Cancellation Policy

Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

ACCME Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

This activity is currently under review for accreditation targeting 3.75 AMA PRA Category 1 Credit(s)^TM.

Deadline to Claim Credit

Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

 Schedule - February 22, 2025 1pm - 5pm - All times Eastern Standard Time (NYC/USA)

Detailed Scheduled coming soon

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendance Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations

ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.